Skip to main content
Top
Published in: Diabetologia 9/2013

01-09-2013 | Review

The prenatal environment and type 1 diabetes

Authors: L. C. Stene, E. A. M. Gale

Published in: Diabetologia | Issue 9/2013

Login to get access

Abstract

There is ample evidence that environmental factors are involved in the aetiology of type 1 diabetes, but the nature and timing of the interactions are poorly understood. The intrauterine environment is known to play a role in the later development of type 2 diabetes, and this review considers a possible role in type 1 diabetes. Autoimmune type 1 diabetes is rare in those diagnosed before 6 months of age, but endogenous autoantibodies predictive of future type 1 diabetes may be detectable by 6–12 months of age, suggesting that environmental factors may operate before this age in some cases. Indirect evidence of a protective effect for the intrauterine environment comes from the observation that mothers with type 1 diabetes are less likely than affected fathers to transmit diabetes to their offspring, although the precise role (if any) is unclear. The risk of childhood-onset type 1 diabetes increases with maternal age at delivery, and with high birthweight, but these associations are weak and heterogeneous, and these factors are unlikely to be directly causally related to type 1 diabetes. No firm conclusion can be drawn from studies of maternal enteroviral infection or from various nutritional exposures. The birth process itself may play a role, as suggested by the slightly increased risk in children born by Caesarean section; lack of contact with maternal bacteria is one suggested mechanism. In sum, there is circumstantial evidence, but no proof of principle, that maternal or intrauterine conditions may modulate genetic risk of type 1 diabetes. The disease process culminating in type 1 diabetes typically begins in early life, but it is not clear whether the trail begins before or after birth.
Literature
1.
go back to reference Galton F (1874) English men of science: their nature and nurture. Macmillan, LondonCrossRef Galton F (1874) English men of science: their nature and nurture. Macmillan, LondonCrossRef
2.
go back to reference Vaag AA, Grunnet LG, Arora GP, Brons C (2012) The thrifty phenotype hypothesis revisited. Diabetologia 55:2085–2088PubMedCrossRef Vaag AA, Grunnet LG, Arora GP, Brons C (2012) The thrifty phenotype hypothesis revisited. Diabetologia 55:2085–2088PubMedCrossRef
3.
go back to reference Hoover RN, Hyer M, Pfeiffer RM et al (2011) Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med 365:1304–1314PubMedCrossRef Hoover RN, Hyer M, Pfeiffer RM et al (2011) Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med 365:1304–1314PubMedCrossRef
4.
go back to reference Stene LC, Magnus P, Lie RT, Søvik O, Joner G, the Norwegian Childhood Diabetes Study Group (2001) Birth weight and childhood onset type 1 diabetes: population based cohort study. BMJ 322:889–892PubMedCrossRef Stene LC, Magnus P, Lie RT, Søvik O, Joner G, the Norwegian Childhood Diabetes Study Group (2001) Birth weight and childhood onset type 1 diabetes: population based cohort study. BMJ 322:889–892PubMedCrossRef
5.
go back to reference Cardwell CR, Stene LC, Joner G et al (2010) Birthweight and the risk of childhood-onset type 1 diabetes: a meta-analysis of observational studies using individual patient data. Diabetologia 53:641–651PubMedCrossRef Cardwell CR, Stene LC, Joner G et al (2010) Birthweight and the risk of childhood-onset type 1 diabetes: a meta-analysis of observational studies using individual patient data. Diabetologia 53:641–651PubMedCrossRef
6.
go back to reference Prescott SL (2010) Allergic disease: understanding how in utero events set the scene. Proc Nutr Soc 69:366–372PubMedCrossRef Prescott SL (2010) Allergic disease: understanding how in utero events set the scene. Proc Nutr Soc 69:366–372PubMedCrossRef
7.
go back to reference Renz H, Brandtzaeg P, Hornef M (2012) The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat Rev Immunol 12:9–23 Renz H, Brandtzaeg P, Hornef M (2012) The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat Rev Immunol 12:9–23
8.
go back to reference Warner JO (2006) Developmental origins of asthma and related allergic disorders. In: Gluckman P, Hanson M (eds) Developmental origins of health and disease. Cambridge University Press, Cambridge, pp 349–369CrossRef Warner JO (2006) Developmental origins of asthma and related allergic disorders. In: Gluckman P, Hanson M (eds) Developmental origins of health and disease. Cambridge University Press, Cambridge, pp 349–369CrossRef
9.
go back to reference Stene LC, Tuomilehto J, Rewers M (2008) Global epidemiology of type 1 diabetes. In: Ekoé J-M, Rewers M, Williams R, Zimmet P (eds) The epidemiology of diabetes mellitus, 2nd edn. Wiley-Blackwell, Chichester, pp 355–383CrossRef Stene LC, Tuomilehto J, Rewers M (2008) Global epidemiology of type 1 diabetes. In: Ekoé J-M, Rewers M, Williams R, Zimmet P (eds) The epidemiology of diabetes mellitus, 2nd edn. Wiley-Blackwell, Chichester, pp 355–383CrossRef
10.
go back to reference Knip M, Simell O (2012) Environmental triggers of type 1 diabetes. Cold Spring Harb Perspect Med 2:a007690PubMedCrossRef Knip M, Simell O (2012) Environmental triggers of type 1 diabetes. Cold Spring Harb Perspect Med 2:a007690PubMedCrossRef
11.
go back to reference Knip M, Virtanen SM, Åkerblom HK (2010) Infant feeding and the risk of type 1 diabetes. Am J Clin Nutr 91:1506S–1513SPubMedCrossRef Knip M, Virtanen SM, Åkerblom HK (2010) Infant feeding and the risk of type 1 diabetes. Am J Clin Nutr 91:1506S–1513SPubMedCrossRef
12.
go back to reference Cardwell CR, Stene LC, Ludvigsson J et al (2012) Breast-feeding and childhood-onset type 1 diabetes: a pooled analysis of individual participant data from 43 observational studies. Diabetes Care 35:2215–2225PubMedCrossRef Cardwell CR, Stene LC, Ludvigsson J et al (2012) Breast-feeding and childhood-onset type 1 diabetes: a pooled analysis of individual participant data from 43 observational studies. Diabetes Care 35:2215–2225PubMedCrossRef
13.
go back to reference Harder T, Roepke K, Diller N, Stechling Y, Dudenhausen JW, Plagemann A (2009) Birth weight, early weight gain, and subsequent risk of type 1 diabetes: systematic review and meta-analysis. Am J Epidemiol 169:1428–1436PubMedCrossRef Harder T, Roepke K, Diller N, Stechling Y, Dudenhausen JW, Plagemann A (2009) Birth weight, early weight gain, and subsequent risk of type 1 diabetes: systematic review and meta-analysis. Am J Epidemiol 169:1428–1436PubMedCrossRef
14.
go back to reference Verbeeten KC, Elks CE, Daneman D, Ong KK (2011) Association between childhood obesity and subsequent type 1 diabetes: a systematic review and meta-analysis. Diabet Med 28:10–18PubMedCrossRef Verbeeten KC, Elks CE, Daneman D, Ong KK (2011) Association between childhood obesity and subsequent type 1 diabetes: a systematic review and meta-analysis. Diabet Med 28:10–18PubMedCrossRef
15.
go back to reference Stene LC, Rewers M (2012) Immunology in the clinic review series; focus on type 1 diabetes and viruses: the enterovirus link to type 1 diabetes: critical review of human studies. Clin Exp Immunol 168:12–23PubMedCrossRef Stene LC, Rewers M (2012) Immunology in the clinic review series; focus on type 1 diabetes and viruses: the enterovirus link to type 1 diabetes: critical review of human studies. Clin Exp Immunol 168:12–23PubMedCrossRef
16.
go back to reference Taylor KW, Hyöty H, Toniolo A, Zuckerman AJ (2012) Diabetes and viruses. Springer, New York Taylor KW, Hyöty H, Toniolo A, Zuckerman AJ (2012) Diabetes and viruses. Springer, New York
17.
go back to reference Atkinson MA, Chervonsky A (2012) Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease. Diabetologia 55:2868–2877PubMedCrossRef Atkinson MA, Chervonsky A (2012) Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease. Diabetologia 55:2868–2877PubMedCrossRef
18.
go back to reference Howard SG, Lee DH (2012) What is the role of human contamination by environmental chemicals in the development of type 1 diabetes? J Epidemiol Community Health 66:479–481PubMedCrossRef Howard SG, Lee DH (2012) What is the role of human contamination by environmental chemicals in the development of type 1 diabetes? J Epidemiol Community Health 66:479–481PubMedCrossRef
19.
go back to reference Bluestone JA, Herold K, Eisenbarth G (2010) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464:1293–1300PubMedCrossRef Bluestone JA, Herold K, Eisenbarth G (2010) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464:1293–1300PubMedCrossRef
21.
22.
go back to reference Hermann R, Knip M, Veijola R et al (2003) Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes—indication of an increased environmental pressure? Diabetologia 46:420–425PubMed Hermann R, Knip M, Veijola R et al (2003) Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes—indication of an increased environmental pressure? Diabetologia 46:420–425PubMed
23.
go back to reference Gillespie KM, Bain SC, Barnett AH et al (2004) The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 364:1699–1700PubMedCrossRef Gillespie KM, Bain SC, Barnett AH et al (2004) The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 364:1699–1700PubMedCrossRef
24.
go back to reference Ziegler AG, Bonifacio E, the BABYDIAB-BABYDIET Study Group (2012) Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes. Diabetologia 55:1937–1943PubMedCrossRef Ziegler AG, Bonifacio E, the BABYDIAB-BABYDIET Study Group (2012) Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes. Diabetologia 55:1937–1943PubMedCrossRef
25.
go back to reference Parikka V, Näntö-Salonen K, Saarinen M et al (2012) Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk. Diabetologia 55:1926–1936PubMedCrossRef Parikka V, Näntö-Salonen K, Saarinen M et al (2012) Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk. Diabetologia 55:1926–1936PubMedCrossRef
26.
go back to reference Hampe CS (2012) Protective role of anti-idiotypic antibodies in autoimmunity—lessons for type 1 diabetes. Autoimmunity 45:320–331PubMedCrossRef Hampe CS (2012) Protective role of anti-idiotypic antibodies in autoimmunity—lessons for type 1 diabetes. Autoimmunity 45:320–331PubMedCrossRef
27.
go back to reference Cleaver O, Melton DA (2005) Development of the endocrine pancreas. In: Kahn CR, Weir GC, King GL, Jacobson AM, Moses AC, Smith RJ (eds) Joslin’s Diabetes Mellitus, 14th edn. Lippincott Williams & Wilkins, Philadelphia, pp 22–39 Cleaver O, Melton DA (2005) Development of the endocrine pancreas. In: Kahn CR, Weir GC, King GL, Jacobson AM, Moses AC, Smith RJ (eds) Joslin’s Diabetes Mellitus, 14th edn. Lippincott Williams & Wilkins, Philadelphia, pp 22–39
28.
go back to reference Lewis DB, Wilson CB (2006) Developmental immunology and role of host defenses in fetal and neonatal susceptibility to infection. In: Remington JS, Klein JO, Wilson CB, Baker CJ (eds) Infectious diseases of the fetus and newborn infant, 6th edn. Elsevier Saunders, Philadelphia, pp 87–210CrossRef Lewis DB, Wilson CB (2006) Developmental immunology and role of host defenses in fetal and neonatal susceptibility to infection. In: Remington JS, Klein JO, Wilson CB, Baker CJ (eds) Infectious diseases of the fetus and newborn infant, 6th edn. Elsevier Saunders, Philadelphia, pp 87–210CrossRef
29.
go back to reference PrabhuDas M, Adkins B, Gans H et al (2011) Challenges in infant immunity: implications for responses to infection and vaccines. Nat Immunol 12:189–194PubMedCrossRef PrabhuDas M, Adkins B, Gans H et al (2011) Challenges in infant immunity: implications for responses to infection and vaccines. Nat Immunol 12:189–194PubMedCrossRef
30.
go back to reference Trowsdale J, Betz AG (2006) Mother’s little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol 7:241–246PubMedCrossRef Trowsdale J, Betz AG (2006) Mother’s little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol 7:241–246PubMedCrossRef
31.
go back to reference Lindberg B, Ivarsson SA, Landin-Olsson M, Sundkvist G, Svanberg L, Lernmark Å (1999) Islet autoantibodies in cord blood from children who developed type I (insulin-dependent) diabetes mellitus before 15 years of age. Diabetologia 42:181–187PubMedCrossRef Lindberg B, Ivarsson SA, Landin-Olsson M, Sundkvist G, Svanberg L, Lernmark Å (1999) Islet autoantibodies in cord blood from children who developed type I (insulin-dependent) diabetes mellitus before 15 years of age. Diabetologia 42:181–187PubMedCrossRef
32.
go back to reference Greeley SA, Katsumata M, Yu L et al (2002) Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med 8:399–402PubMedCrossRef Greeley SA, Katsumata M, Yu L et al (2002) Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med 8:399–402PubMedCrossRef
33.
go back to reference Koczwara K, Bonifacio E, Ziegler AG (2004) Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes. Diabetes 53:1–4PubMedCrossRef Koczwara K, Bonifacio E, Ziegler AG (2004) Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes. Diabetes 53:1–4PubMedCrossRef
34.
go back to reference Rewers M (2002) Islet autoantibodies in cord blood: maternal, fetal, or neither? Diabetes Metab Res Rev 18:2–4PubMedCrossRef Rewers M (2002) Islet autoantibodies in cord blood: maternal, fetal, or neither? Diabetes Metab Res Rev 18:2–4PubMedCrossRef
35.
go back to reference Stene LC, Witsø E, Torjesen PA et al (2007) Islet autoantibody development during follow-up of high-risk children from the general Norwegian population from three months of age: design and early results from the MIDIA study. J Autoimmun 29:44–51PubMedCrossRef Stene LC, Witsø E, Torjesen PA et al (2007) Islet autoantibody development during follow-up of high-risk children from the general Norwegian population from three months of age: design and early results from the MIDIA study. J Autoimmun 29:44–51PubMedCrossRef
37.
go back to reference Åkesson K, Carlsson A, Ivarsson SA et al (2009) The non-inherited maternal HLA haplotype affects the risk for type 1 diabetes. Int J Immunogenet 36:1–8PubMedCrossRef Åkesson K, Carlsson A, Ivarsson SA et al (2009) The non-inherited maternal HLA haplotype affects the risk for type 1 diabetes. Int J Immunogenet 36:1–8PubMedCrossRef
38.
go back to reference Bronson PG, Ramsay PP, Thomson G, Barcellos LF (2009) Analysis of maternal–offspring HLA compatibility, parent-of-origin and non-inherited maternal effects for the classical HLA loci in type 1 diabetes. Diabetes Obes Metab 11(Suppl 1):74–83PubMedCrossRef Bronson PG, Ramsay PP, Thomson G, Barcellos LF (2009) Analysis of maternal–offspring HLA compatibility, parent-of-origin and non-inherited maternal effects for the classical HLA loci in type 1 diabetes. Diabetes Obes Metab 11(Suppl 1):74–83PubMedCrossRef
39.
go back to reference Nistico L, Iafusco D, Galderisi A et al (2012) Emerging effects of early environmental factors over genetic background for type 1 diabetes susceptibility: evidence from a nationwide Italian twin study. J Clin Endocrinol Metab 97:E1483–E1491PubMedCrossRef Nistico L, Iafusco D, Galderisi A et al (2012) Emerging effects of early environmental factors over genetic background for type 1 diabetes susceptibility: evidence from a nationwide Italian twin study. J Clin Endocrinol Metab 97:E1483–E1491PubMedCrossRef
40.
go back to reference Condon J, Shaw JE, Luciano M, Kyvik KO, Martin NG, Duffy DL (2008) A study of diabetes mellitus within a large sample of Australian twins. Twin Res Hum Genet 11:28–40PubMedCrossRef Condon J, Shaw JE, Luciano M, Kyvik KO, Martin NG, Duffy DL (2008) A study of diabetes mellitus within a large sample of Australian twins. Twin Res Hum Genet 11:28–40PubMedCrossRef
41.
go back to reference Hyttinen V, Kaprio J, Kinnunen L, Koskenvuo M, Tuomilehto J (2003) Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes 52:1052–1055PubMedCrossRef Hyttinen V, Kaprio J, Kinnunen L, Koskenvuo M, Tuomilehto J (2003) Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes 52:1052–1055PubMedCrossRef
42.
go back to reference Kyvik KO, Green A, Beck-Nielsen H (1995) Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. BMJ 311:913–917PubMedCrossRef Kyvik KO, Green A, Beck-Nielsen H (1995) Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. BMJ 311:913–917PubMedCrossRef
43.
go back to reference Kaprio J, Tuomilehto J, Koskenvuo M et al (1992) Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 35:1060–1067PubMedCrossRef Kaprio J, Tuomilehto J, Koskenvuo M et al (1992) Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 35:1060–1067PubMedCrossRef
44.
go back to reference Harjutsalo V, Podar T, Tuomilehto J (2005) Cumulative incidence of type 1 diabetes in 10,168 siblings of Finnish young-onset type 1 diabetic patients. Diabetes 54:563–569PubMedCrossRef Harjutsalo V, Podar T, Tuomilehto J (2005) Cumulative incidence of type 1 diabetes in 10,168 siblings of Finnish young-onset type 1 diabetic patients. Diabetes 54:563–569PubMedCrossRef
45.
go back to reference Lorenzen T, Pociot F, Hougaard P, Nerup J (1994) Long-term risk of IDDM in first-degree relatives of patients with IDDM. Diabetologia 37:321–327PubMedCrossRef Lorenzen T, Pociot F, Hougaard P, Nerup J (1994) Long-term risk of IDDM in first-degree relatives of patients with IDDM. Diabetologia 37:321–327PubMedCrossRef
46.
go back to reference Warram JH, Krolewski AS, Gottlieb MS, Kahn CR (1984) Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med 311:149–152PubMedCrossRef Warram JH, Krolewski AS, Gottlieb MS, Kahn CR (1984) Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med 311:149–152PubMedCrossRef
47.
go back to reference Lorenzen T, Pociot F, Stilgren L et al (1998) Predictors of IDDM recurrence risk in offspring of Danish IDDM patients. Danish IDDM Epidemiology and Genetics Group. Diabetologia 41:666–673PubMedCrossRef Lorenzen T, Pociot F, Stilgren L et al (1998) Predictors of IDDM recurrence risk in offspring of Danish IDDM patients. Danish IDDM Epidemiology and Genetics Group. Diabetologia 41:666–673PubMedCrossRef
48.
go back to reference Harjutsalo V, Reunanen A, Tuomilehto J (2006) Differential transmission of type 1 diabetes from diabetic fathers and mothers to their offspring. Diabetes 55:1517–1524PubMedCrossRef Harjutsalo V, Reunanen A, Tuomilehto J (2006) Differential transmission of type 1 diabetes from diabetic fathers and mothers to their offspring. Diabetes 55:1517–1524PubMedCrossRef
49.
go back to reference Hemminki K, Li X, Sundquist J, Sundquist K (2009) Familial association between type 1 diabetes and other autoimmune and related diseases. Diabetologia 52:1820–1828PubMedCrossRef Hemminki K, Li X, Sundquist J, Sundquist K (2009) Familial association between type 1 diabetes and other autoimmune and related diseases. Diabetologia 52:1820–1828PubMedCrossRef
50.
go back to reference Bonifacio E, Pflüger M, Marienfeld S, Winkler C, Hummel M, Ziegler AG (2008) Maternal type 1 diabetes reduces the risk of islet autoantibodies: relationships with birthweight and maternal HbA1c. Diabetologia 51:1245–1252PubMedCrossRef Bonifacio E, Pflüger M, Marienfeld S, Winkler C, Hummel M, Ziegler AG (2008) Maternal type 1 diabetes reduces the risk of islet autoantibodies: relationships with birthweight and maternal HbA1c. Diabetologia 51:1245–1252PubMedCrossRef
51.
go back to reference Gillespie KM, Gale EA, Bingley PJ (2002) High familial risk and genetic susceptibility in early onset childhood diabetes. Diabetes 51:210–214PubMedCrossRef Gillespie KM, Gale EA, Bingley PJ (2002) High familial risk and genetic susceptibility in early onset childhood diabetes. Diabetes 51:210–214PubMedCrossRef
52.
go back to reference Redondo MJ, Yu L, Hawa M et al (2001) Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 44:354–362PubMedCrossRef Redondo MJ, Yu L, Hawa M et al (2001) Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 44:354–362PubMedCrossRef
53.
go back to reference Harjutsalo V, Lammi N, Karvonen M, Groop PH (2010) Age at onset of type 1 diabetes in parents and recurrence risk in offspring. Diabetes 59:210–214PubMedCrossRef Harjutsalo V, Lammi N, Karvonen M, Groop PH (2010) Age at onset of type 1 diabetes in parents and recurrence risk in offspring. Diabetes 59:210–214PubMedCrossRef
54.
go back to reference Tillil H, Köbberling J (1987) Age-corrected empirical genetic risk estimates for first-degree relatives of IDDM patients. Diabetes 36:93–99PubMedCrossRef Tillil H, Köbberling J (1987) Age-corrected empirical genetic risk estimates for first-degree relatives of IDDM patients. Diabetes 36:93–99PubMedCrossRef
55.
go back to reference Bleich D, Polak M, Eisenbarth GS, Jackson RA (1993) Decreased risk of type I diabetes in offspring of mothers who acquire diabetes during adrenarchy. Diabetes 42:1433–1439PubMedCrossRef Bleich D, Polak M, Eisenbarth GS, Jackson RA (1993) Decreased risk of type I diabetes in offspring of mothers who acquire diabetes during adrenarchy. Diabetes 42:1433–1439PubMedCrossRef
56.
go back to reference Cardwell CR, Stene LC, Joner G et al (2008) Caesarean section is associated with an increased risk of childhood onset type 1 diabetes: a meta-analysis of observational studies. Diabetologia 51:726–735PubMedCrossRef Cardwell CR, Stene LC, Joner G et al (2008) Caesarean section is associated with an increased risk of childhood onset type 1 diabetes: a meta-analysis of observational studies. Diabetologia 51:726–735PubMedCrossRef
57.
go back to reference Cardwell CR, Stene LC, Joner G et al (2010) Maternal age at birth and childhood type 1 diabetes: a pooled analysis of 30 observational studies. Diabetes 59:486–494PubMedCrossRef Cardwell CR, Stene LC, Joner G et al (2010) Maternal age at birth and childhood type 1 diabetes: a pooled analysis of 30 observational studies. Diabetes 59:486–494PubMedCrossRef
58.
go back to reference Cardwell CR, Stene LC, Joner G et al (2011) Birth order and childhood type 1 diabetes risk: a pooled analysis of 31 observational studies. Int J Epidemiol 40:363–374PubMedCrossRef Cardwell CR, Stene LC, Joner G et al (2011) Birth order and childhood type 1 diabetes risk: a pooled analysis of 31 observational studies. Int J Epidemiol 40:363–374PubMedCrossRef
59.
go back to reference Cardwell CR, Svensson J, Waldhoer T et al (2012) Interbirth interval is associated with childhood type 1 diabetes risk. Diabetes 61:702–707PubMedCrossRef Cardwell CR, Svensson J, Waldhoer T et al (2012) Interbirth interval is associated with childhood type 1 diabetes risk. Diabetes 61:702–707PubMedCrossRef
60.
go back to reference Henry EB, Patterson CC, Cardwell CR (2011) A meta-analysis of the association between pre-eclampsia and childhood-onset type 1 diabetes mellitus. Diabet Med 28:900–905PubMedCrossRef Henry EB, Patterson CC, Cardwell CR (2011) A meta-analysis of the association between pre-eclampsia and childhood-onset type 1 diabetes mellitus. Diabet Med 28:900–905PubMedCrossRef
61.
go back to reference McNamee MB, Cardwell CR, Patterson CC (2012) Neonatal jaundice is associated with a small increase in the risk of childhood type 1 diabetes: a meta-analysis of observational studies. Acta Diabetol 49:83–87PubMedCrossRef McNamee MB, Cardwell CR, Patterson CC (2012) Neonatal jaundice is associated with a small increase in the risk of childhood type 1 diabetes: a meta-analysis of observational studies. Acta Diabetol 49:83–87PubMedCrossRef
62.
go back to reference Stene LC, Barriga K, Norris JM et al (2004) Perinatal factors and development of islet autoimmunity in early childhood: the Diabetes Autoimmunity Study in the Young. Am J Epidemiol 160:3–10PubMedCrossRef Stene LC, Barriga K, Norris JM et al (2004) Perinatal factors and development of islet autoimmunity in early childhood: the Diabetes Autoimmunity Study in the Young. Am J Epidemiol 160:3–10PubMedCrossRef
63.
go back to reference Hummel M, Schenker M, Ziegler AG (2001) Influence of perinatal factors on the appearance of islet autoantibodies in offspring of parents with type 1 diabetes. Pediatr Diabetes 2:40–42PubMed Hummel M, Schenker M, Ziegler AG (2001) Influence of perinatal factors on the appearance of islet autoantibodies in offspring of parents with type 1 diabetes. Pediatr Diabetes 2:40–42PubMed
64.
go back to reference Struwe FE (1960) On the manifestation of diabetes mellitus in childhood (age of manifestation, maternal age at birth, familial diabetes). Monatsschr Kinderheilkd 108:487–490 [article in German]PubMed Struwe FE (1960) On the manifestation of diabetes mellitus in childhood (age of manifestation, maternal age at birth, familial diabetes). Monatsschr Kinderheilkd 108:487–490 [article in German]PubMed
65.
go back to reference Flood TM, Brink SJ, Gleason RE (1982) Increased incidence of type I diabetes in children of older mothers. Diabetes Care 6:571–573CrossRef Flood TM, Brink SJ, Gleason RE (1982) Increased incidence of type I diabetes in children of older mothers. Diabetes Care 6:571–573CrossRef
66.
go back to reference Deschamps I, Lestradet H, Busson M, Hors J (1984) Evaluation of recurrence risk in siblings of diabetic children: importance of age and birth order in relation to HLA genotypes. Diabetes Res 1:125–130PubMed Deschamps I, Lestradet H, Busson M, Hors J (1984) Evaluation of recurrence risk in siblings of diabetic children: importance of age and birth order in relation to HLA genotypes. Diabetes Res 1:125–130PubMed
67.
go back to reference Dahlquist G, Källén B (1992) Maternal-child blood group incompatibility and other perinatal events increase the risk for early-onset type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:671–675PubMedCrossRef Dahlquist G, Källén B (1992) Maternal-child blood group incompatibility and other perinatal events increase the risk for early-onset type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:671–675PubMedCrossRef
68.
go back to reference Ng SF, Lin RC, Laybutt DR, Barres R, Owens JA, Morris MJ (2010) Chronic high-fat diet in fathers programs beta-cell dysfunction in female rat offspring. Nature 467:963–966PubMedCrossRef Ng SF, Lin RC, Laybutt DR, Barres R, Owens JA, Morris MJ (2010) Chronic high-fat diet in fathers programs beta-cell dysfunction in female rat offspring. Nature 467:963–966PubMedCrossRef
69.
go back to reference Carone BR, Fauquier L, Habib N et al (2010) Paternally induced transgenerational environmental reprogramming of metabolic gene expression in mammals. Cell 143:1084–1096PubMedCrossRef Carone BR, Fauquier L, Habib N et al (2010) Paternally induced transgenerational environmental reprogramming of metabolic gene expression in mammals. Cell 143:1084–1096PubMedCrossRef
71.
go back to reference Bonifacio E, Warncke K, Winkler C, Wallner M, Ziegler AG (2011) Cesarean section and interferon-induced helicase gene polymorphisms combine to increase childhood type 1 diabetes risk. Diabetes 60:3300–3306PubMedCrossRef Bonifacio E, Warncke K, Winkler C, Wallner M, Ziegler AG (2011) Cesarean section and interferon-induced helicase gene polymorphisms combine to increase childhood type 1 diabetes risk. Diabetes 60:3300–3306PubMedCrossRef
72.
go back to reference Dominguez-Bello MG, Costello EK, Contreras M et al (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 107:11971–11975PubMedCrossRef Dominguez-Bello MG, Costello EK, Contreras M et al (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 107:11971–11975PubMedCrossRef
73.
go back to reference Stene LC, Thorsby PM, Berg JP et al (2006) The relation between size at birth and risk of type 1 diabetes is not influenced by adjustment for the insulin gene (-23HphI) polymorphism or HLA-DQ genotype. Diabetologia 49:2068–2073PubMedCrossRef Stene LC, Thorsby PM, Berg JP et al (2006) The relation between size at birth and risk of type 1 diabetes is not influenced by adjustment for the insulin gene (-23HphI) polymorphism or HLA-DQ genotype. Diabetologia 49:2068–2073PubMedCrossRef
74.
go back to reference Brown RJ, Rother KI (2008) Effects of beta-cell rest on beta-cell function: a review of clinical and preclinical data. Pediatr Diabetes 9:14–22PubMedCrossRef Brown RJ, Rother KI (2008) Effects of beta-cell rest on beta-cell function: a review of clinical and preclinical data. Pediatr Diabetes 9:14–22PubMedCrossRef
75.
go back to reference Pang TT, Narendran P (2008) Addressing insulin resistance in type 1 diabetes. Diabet Med 25:1015–1024PubMedCrossRef Pang TT, Narendran P (2008) Addressing insulin resistance in type 1 diabetes. Diabet Med 25:1015–1024PubMedCrossRef
76.
go back to reference Robertson L, Harrild K (2010) Maternal and neonatal risk factors for childhood type 1 diabetes: a matched case–control study. BMC Publ Health 10:281CrossRef Robertson L, Harrild K (2010) Maternal and neonatal risk factors for childhood type 1 diabetes: a matched case–control study. BMC Publ Health 10:281CrossRef
77.
go back to reference Marshall AL, Chetwynd A, Morris JA et al (2004) Type 1 diabetes mellitus in childhood: a matched case control study in Lancashire and Cumbria, UK. Diabet Med 21:1035–1040PubMedCrossRef Marshall AL, Chetwynd A, Morris JA et al (2004) Type 1 diabetes mellitus in childhood: a matched case control study in Lancashire and Cumbria, UK. Diabet Med 21:1035–1040PubMedCrossRef
78.
go back to reference Hjern A, Söderström U (2008) Parental country of birth is a major determinant of childhood type 1 diabetes in Sweden. Pediatr Diabetes 9:35–39PubMed Hjern A, Söderström U (2008) Parental country of birth is a major determinant of childhood type 1 diabetes in Sweden. Pediatr Diabetes 9:35–39PubMed
79.
go back to reference Ievins R, Roberts SE, Goldacre MJ (2007) Perinatal factors associated with subsequent diabetes mellitus in the child: record linkage study. Diabet Med 24:664–670PubMedCrossRef Ievins R, Roberts SE, Goldacre MJ (2007) Perinatal factors associated with subsequent diabetes mellitus in the child: record linkage study. Diabet Med 24:664–670PubMedCrossRef
80.
go back to reference Rasmussen T, Witsø E, Tapia G, Stene LC, Rønningen KS (2011) Self-reported lower respiratory tract infections and development of islet autoimmunity in children with the type 1 diabetes high-risk HLA genotype: the MIDIA study. Diabetes Metab Res Rev 27:834–837PubMedCrossRef Rasmussen T, Witsø E, Tapia G, Stene LC, Rønningen KS (2011) Self-reported lower respiratory tract infections and development of islet autoimmunity in children with the type 1 diabetes high-risk HLA genotype: the MIDIA study. Diabetes Metab Res Rev 27:834–837PubMedCrossRef
81.
go back to reference Virtanen SM, Kenward MG, Erkkola M et al (2006) Age at introduction of new foods and advanced beta cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes. Diabetologia 49:1512–1521PubMedCrossRef Virtanen SM, Kenward MG, Erkkola M et al (2006) Age at introduction of new foods and advanced beta cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes. Diabetologia 49:1512–1521PubMedCrossRef
82.
go back to reference Ng SP, Zelikoff JT (2007) Smoking during pregnancy: subsequent effects on offspring immune competence and disease vulnerability in later life. Reprod Toxicol 23:428–437PubMedCrossRef Ng SP, Zelikoff JT (2007) Smoking during pregnancy: subsequent effects on offspring immune competence and disease vulnerability in later life. Reprod Toxicol 23:428–437PubMedCrossRef
83.
go back to reference Joubert BR, Håberg SE, Nilsen RM et al (2012) 450K Epigenome-wide scan identifies differential DNA methylation in newborns related to maternal smoking during pregnancy. Environ Health Perspect 120:1425–1431PubMed Joubert BR, Håberg SE, Nilsen RM et al (2012) 450K Epigenome-wide scan identifies differential DNA methylation in newborns related to maternal smoking during pregnancy. Environ Health Perspect 120:1425–1431PubMed
84.
go back to reference Menser MA, Dods L, Harley JD (1967) A twenty-five-year follow-up of congenital rubella. Lancet 2:1347–1350PubMedCrossRef Menser MA, Dods L, Harley JD (1967) A twenty-five-year follow-up of congenital rubella. Lancet 2:1347–1350PubMedCrossRef
85.
go back to reference Forrest JM, Turnbull FM, Sholler GF et al (2002) Gregg’s congenital rubella patients 60 years later. Med J Aust 177:664–667PubMed Forrest JM, Turnbull FM, Sholler GF et al (2002) Gregg’s congenital rubella patients 60 years later. Med J Aust 177:664–667PubMed
86.
go back to reference Forrest JM, Menser MA, Burgess JA (1971) High frequency of diabetes mellitus in young adults with congenital rubella. Lancet 2:332–334PubMedCrossRef Forrest JM, Menser MA, Burgess JA (1971) High frequency of diabetes mellitus in young adults with congenital rubella. Lancet 2:332–334PubMedCrossRef
87.
go back to reference Gale EA (2008) Congenital rubella: citation virus or viral cause of type 1 diabetes? Diabetologia 51:1559–1566PubMedCrossRef Gale EA (2008) Congenital rubella: citation virus or viral cause of type 1 diabetes? Diabetologia 51:1559–1566PubMedCrossRef
88.
go back to reference Viskari H, Knip M, Tauriainen S et al (2012) Maternal enterovirus infection as a risk factor for type 1 diabetes in the exposed offspring. Diabetes Care 35:1328–1332PubMedCrossRef Viskari H, Knip M, Tauriainen S et al (2012) Maternal enterovirus infection as a risk factor for type 1 diabetes in the exposed offspring. Diabetes Care 35:1328–1332PubMedCrossRef
89.
go back to reference Lamb MM, Myers MA, Barriga K, Zimmet PZ, Rewers M, Norris JM (2008) Maternal diet during pregnancy and islet autoimmunity in offspring. Pediatr Diabetes 9:135–141PubMedCrossRef Lamb MM, Myers MA, Barriga K, Zimmet PZ, Rewers M, Norris JM (2008) Maternal diet during pregnancy and islet autoimmunity in offspring. Pediatr Diabetes 9:135–141PubMedCrossRef
90.
go back to reference Virtanen SM, Uusitalo L, Kenward MG et al (2011) Maternal food consumption during pregnancy and risk of advanced beta-cell autoimmunity in the offspring. Pediatr Diabetes 12:95–99PubMedCrossRef Virtanen SM, Uusitalo L, Kenward MG et al (2011) Maternal food consumption during pregnancy and risk of advanced beta-cell autoimmunity in the offspring. Pediatr Diabetes 12:95–99PubMedCrossRef
91.
go back to reference Stene LC, Ulriksen J, Magnus P, Joner G (2000) Use of cod liver oil during pregnancy associated with lower risk of type I diabetes in the offspring. Diabetologia 43:1083–1092CrossRef Stene LC, Ulriksen J, Magnus P, Joner G (2000) Use of cod liver oil during pregnancy associated with lower risk of type I diabetes in the offspring. Diabetologia 43:1083–1092CrossRef
92.
go back to reference Sørensen IM, Joner G, Jenum PA, Eskild A, Stene LC (2012) Serum long chain n-3 fatty acids (EPA and DHA) in the pregnant mother are independent of risk of type 1 diabetes in the offspring. Diabetes Metab Res Rev 28:431–438PubMedCrossRef Sørensen IM, Joner G, Jenum PA, Eskild A, Stene LC (2012) Serum long chain n-3 fatty acids (EPA and DHA) in the pregnant mother are independent of risk of type 1 diabetes in the offspring. Diabetes Metab Res Rev 28:431–438PubMedCrossRef
93.
go back to reference Oresic M, Simell S, Sysi-Aho M et al (2008) Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med 205:2975–2984PubMedCrossRef Oresic M, Simell S, Sysi-Aho M et al (2008) Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med 205:2975–2984PubMedCrossRef
94.
go back to reference Erkkola M, Nwaru BI, Viljakainen HT (2011) Maternal vitamin D during pregnancy and its relation to immune-mediated diseases in the offspring. Vitam Horm 86:239–260PubMedCrossRef Erkkola M, Nwaru BI, Viljakainen HT (2011) Maternal vitamin D during pregnancy and its relation to immune-mediated diseases in the offspring. Vitam Horm 86:239–260PubMedCrossRef
95.
go back to reference Zehnder D, Evans KN, Kilby MD et al (2002) The ontogeny of 25-hydroxyvitamin D3 1α-hydroxylase expression in human placenta and decidua. Am J Pathol 161:105–114PubMedCrossRef Zehnder D, Evans KN, Kilby MD et al (2002) The ontogeny of 25-hydroxyvitamin D3 1α-hydroxylase expression in human placenta and decidua. Am J Pathol 161:105–114PubMedCrossRef
96.
go back to reference Marjamäki L, Niinistö S, Kenward MG et al (2010) Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring. Diabetologia 53:1599–1607PubMedCrossRef Marjamäki L, Niinistö S, Kenward MG et al (2010) Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring. Diabetologia 53:1599–1607PubMedCrossRef
97.
go back to reference Sørensen IM, Joner G, Jenum PA, Eskild A, Torjesen PA, Stene LC (2012) Maternal serum levels of 25-hydroxy-vitamin D during pregnancy and risk of type 1 diabetes in the offspring. Diabetes 61:175–178PubMedCrossRef Sørensen IM, Joner G, Jenum PA, Eskild A, Torjesen PA, Stene LC (2012) Maternal serum levels of 25-hydroxy-vitamin D during pregnancy and risk of type 1 diabetes in the offspring. Diabetes 61:175–178PubMedCrossRef
98.
go back to reference Miettinen ME, Reinert L, Kinnunen L et al (2012) Serum 25-hydroxyvitamin D level during early pregnancy and type 1 diabetes risk in the offspring. Diabetologia 55:1291–1294PubMedCrossRef Miettinen ME, Reinert L, Kinnunen L et al (2012) Serum 25-hydroxyvitamin D level during early pregnancy and type 1 diabetes risk in the offspring. Diabetologia 55:1291–1294PubMedCrossRef
99.
go back to reference The TRIGR Study Group (2011) The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up. Diabetologia 54:627–633CrossRef The TRIGR Study Group (2011) The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up. Diabetologia 54:627–633CrossRef
100.
go back to reference Knip M, Virtanen SM, Seppa K et al (2010) Dietary intervention in infancy and later signs of beta-cell autoimmunity. N Engl J Med 363:1900–1908PubMedCrossRef Knip M, Virtanen SM, Seppa K et al (2010) Dietary intervention in infancy and later signs of beta-cell autoimmunity. N Engl J Med 363:1900–1908PubMedCrossRef
101.
go back to reference Vaarala O, Ilonen J, Ruohtula T et al (2012) Removal of bovine insulin from cow’s milk formula and early initiation of beta-cell autoimmunity in the FINDIA pilot study. Arch Pediatr Adolesc Med 166:608–614PubMedCrossRef Vaarala O, Ilonen J, Ruohtula T et al (2012) Removal of bovine insulin from cow’s milk formula and early initiation of beta-cell autoimmunity in the FINDIA pilot study. Arch Pediatr Adolesc Med 166:608–614PubMedCrossRef
102.
go back to reference Giulietti A, Gysemans C, Stoffels K et al (2004) Vitamin D deficiency in early life accelerates type 1 diabetes in non-obese diabetic mice. Diabetologia 47:451–462PubMedCrossRef Giulietti A, Gysemans C, Stoffels K et al (2004) Vitamin D deficiency in early life accelerates type 1 diabetes in non-obese diabetic mice. Diabetologia 47:451–462PubMedCrossRef
103.
go back to reference Hawa MI, Valorani MG, Buckley LR et al (2004) Lack of effect of vitamin D administration during pregnancy and early life on diabetes incidence in the non-obese diabetic mouse. Horm Metab Res 36:620–624PubMedCrossRef Hawa MI, Valorani MG, Buckley LR et al (2004) Lack of effect of vitamin D administration during pregnancy and early life on diabetes incidence in the non-obese diabetic mouse. Horm Metab Res 36:620–624PubMedCrossRef
104.
go back to reference Oge A, Isganaitis E, Jimenez-Chillaron J et al (2007) In utero undernutrition reduces diabetes incidence in non-obese diabetic mice. Diabetologia 50:1099–1108PubMedCrossRef Oge A, Isganaitis E, Jimenez-Chillaron J et al (2007) In utero undernutrition reduces diabetes incidence in non-obese diabetic mice. Diabetologia 50:1099–1108PubMedCrossRef
105.
go back to reference Maloney S, Smith A, Furst DE et al (1999) Microchimerism of maternal origin persists into adult life. J Clin Invest 104:41–47PubMedCrossRef Maloney S, Smith A, Furst DE et al (1999) Microchimerism of maternal origin persists into adult life. J Clin Invest 104:41–47PubMedCrossRef
106.
go back to reference Mold JE, Michaelsson J, Burt TD et al (2008) Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 322:1562–1565PubMedCrossRef Mold JE, Michaelsson J, Burt TD et al (2008) Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 322:1562–1565PubMedCrossRef
107.
go back to reference Nelson JL, Gillespie KM, Lambert NC et al (2007) Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet β cell microchimerism. Proc Natl Acad Sci U S A 104:1637–1642PubMedCrossRef Nelson JL, Gillespie KM, Lambert NC et al (2007) Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet β cell microchimerism. Proc Natl Acad Sci U S A 104:1637–1642PubMedCrossRef
108.
go back to reference vanZyl B, Planas R, Ye Y et al (2010) Why are levels of maternal microchimerism higher in type 1 diabetes pancreas? Chimerism 1:45–50PubMedCrossRef vanZyl B, Planas R, Ye Y et al (2010) Why are levels of maternal microchimerism higher in type 1 diabetes pancreas? Chimerism 1:45–50PubMedCrossRef
109.
go back to reference MacFarlane AJ, Strom A, Scott FW (2009) Epigenetics: deciphering how environmental factors may modify autoimmune type 1 diabetes. Mamm Genome 20:624–632PubMedCrossRef MacFarlane AJ, Strom A, Scott FW (2009) Epigenetics: deciphering how environmental factors may modify autoimmune type 1 diabetes. Mamm Genome 20:624–632PubMedCrossRef
110.
go back to reference Hochberg Z, Feil R, Constancia M et al (2011) Child health, developmental plasticity, and epigenetic programming. Endocr Rev 32:159–224PubMedCrossRef Hochberg Z, Feil R, Constancia M et al (2011) Child health, developmental plasticity, and epigenetic programming. Endocr Rev 32:159–224PubMedCrossRef
111.
go back to reference Khulan B, Cooper WN, Skinner BM et al (2012) Periconceptional maternal micronutrient supplementation is associated with widespread gender related changes in the epigenome: a study of a unique resource in the Gambia. Hum Mol Genet 21:2086–2101PubMedCrossRef Khulan B, Cooper WN, Skinner BM et al (2012) Periconceptional maternal micronutrient supplementation is associated with widespread gender related changes in the epigenome: a study of a unique resource in the Gambia. Hum Mol Genet 21:2086–2101PubMedCrossRef
112.
go back to reference Relton CL, Davey SG (2010) Epigenetic epidemiology of common complex disease: prospects for prediction, prevention, and treatment. PLoS Med 7:e1000356PubMedCrossRef Relton CL, Davey SG (2010) Epigenetic epidemiology of common complex disease: prospects for prediction, prevention, and treatment. PLoS Med 7:e1000356PubMedCrossRef
113.
go back to reference Rakyan VK, Down TA, Balding DJ, Beck S (2011) Epigenome-wide association studies for common human diseases. Nat Rev Genet 12:529–541PubMedCrossRef Rakyan VK, Down TA, Balding DJ, Beck S (2011) Epigenome-wide association studies for common human diseases. Nat Rev Genet 12:529–541PubMedCrossRef
114.
go back to reference Rakyan VK, Beyan H, Down TA et al (2011) Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. PLoS Genet 7:e1002300PubMedCrossRef Rakyan VK, Beyan H, Down TA et al (2011) Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. PLoS Genet 7:e1002300PubMedCrossRef
115.
go back to reference Stene LC, Rønningen KS, Undlien DE, Joner G (2011) Does the relative risk for type 1 diabetes conferred by HLA-DQ, INS, and PTPN22 polymorphisms vary with maternal age, birth weight, or cesarean section? Pediatr Diabetes 12:91–94PubMedCrossRef Stene LC, Rønningen KS, Undlien DE, Joner G (2011) Does the relative risk for type 1 diabetes conferred by HLA-DQ, INS, and PTPN22 polymorphisms vary with maternal age, birth weight, or cesarean section? Pediatr Diabetes 12:91–94PubMedCrossRef
Metadata
Title
The prenatal environment and type 1 diabetes
Authors
L. C. Stene
E. A. M. Gale
Publication date
01-09-2013
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 9/2013
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-2929-6

Other articles of this Issue 9/2013

Diabetologia 9/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.